Table 4.
Model 1 | Model 2 | Model 3 | Model 4 | |||||
---|---|---|---|---|---|---|---|---|
OR | 95% CI | OR | 95% CI | OR | 95% CI | OR | 95% CI | |
Waist circumference † | ||||||||
Normal (ref) (n=277) | 1 | 1 | 1 | |||||
Increased (n=285) | 2.10 | 1.23–3.58 | 1.58 | 0.82–3.05 | 1.45 | 0.74–2.85 | ||
Large (n=382) | 4.34 | 2.60–7.26 | 3.25 | 1.64–6.44 | 2.89 | 1.42–5.86 | ||
Cytokines ‡ | ||||||||
Log CRP (mg/L) | 1.00 | 0.78–1.28 | 0.95 | 0.74–1.22 | 0.87 | 0.67–1.14 | ||
Log IL-6 (pg/mL) | 1.07 | 0.83–1.36 | 1.08 | 0.84–1.39 | 1.01 | 0.77–1.31 | ||
Log IL-1ra (pg/mL) | 1.42 | 1.08–1.86 | 1.40 | 1.07–1.83 | 1.73 | 1.28–2.33 | ||
Log IL-18 (pg/mL) | 1.21 | 0.96–1.52 | 1.21 | 0.96–1.53 | 1.22 | 0.96–1.56 | ||
Log TNF-α R1 (pg/mL) | 1.21 | 0.95–1.55 | 1.21 | 0.95–1.56 | 1.17 | 0.90–1.51 | ||
Adipokines ‡ | ||||||||
Log Adiponectin (ng/mL) | 0.50 | 0.40–0.62 | 0.50 | 0.41–0.63 | 0.49 | 0.39–0.62 | ||
Log Leptin (ng/mL) | 1.42 | 1.08–1.86 | 1.14 | 0.85–1.54 | 1.08 | 0.79–1.48 | ||
Log Resistin (ng/mL) | 1.04 | 0.83–1.30 | 1.05 | 0.84–1.32 | 1.01 | 0.79–1.29 |
Metabolic syndrome defined without waist circumference component.
Normal < 80 cm in women and < 94 cm in men; Increased 80–87cm in women and 94–101 cm in men; Large ≥ 88 cm in women and ≥ 102 cm in men.
Adipocytokines are presented as standardized values and OR indicates odds per standard deviation (SD) increment in adipocytokine.
Model 1 included BMI, age and sex. Model 2 included adipocytokines, age and sex. Model 3 included BMI, adipocytokines, age and sex. Model 4 included BMI, adipocytokines, age, sex, education, physical activity, smoking and alcohol consumption.
OR = odds ratio; CI = confidence interval; CRP = C-reactive protein (standard deviation SD=1.05 mg/L); IL-6 = interleukin 6 (SD=0.84 pg/mL); IL-1ra = interleukin 1 receptor antagonist (SD=0.57 pg/mL); IL-18 = interleukin 18 (SD=0.35 pg/mL), TNF-α R1 = tumor necrosis factor- α receptor 1 (SD=0.35 pg/mL). Adiponectin SD=0.73 ng/mL; Leptin SD=1.04 ng/mL; Resistin SD=0.45 ng/mL.